Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  thiotepa
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-25 of 49 for your search:
Start Over
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 59
Sponsor: Other
Protocol IDs: M09TNM, 2009-015238-31, NCT01057069
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 6 months to less than 18 years
Sponsor: Other
Protocol IDs: ALL SCTped FORUM 2012, NCT01949129
High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: N12OLG, 2012-000838-19, NCT01646034
Allo-Allo Tandem Bone Marrow Transplant (BMT)
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 3 to 50
Sponsor: Other
Protocol IDs: MYS-07-HMO-CTIL, NCT00984412
Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 54
Sponsor: Other
Protocol IDs: BELEHAPLO-1412001, NCT01220544
Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 5 and under
Sponsor: Other
Protocol IDs: 2012-004842-14, 2012/1908, NCT02025881
Haplo-identical SCT for HR Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: SCT 0813 Haplo, NCT02053545
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 22
Sponsor: Other
Protocol IDs: AAAK8060, NCT02061800
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Phase: Phase II
Type: Treatment
Status: Active
Age: 10 to 69
Sponsor: Other
Protocol IDs: 2006LS032, UMN-MT2005-21, UMN-0608M90586, UMN-2006LS032, NCT00432094
Allogenic Stem Cell Transplantation (SCT) With Non-Myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: GELTAMO-Z-RIC-Allo, EuDRACT nº:2007-003302-10, NCT00644371
Freiburg ZNS-NHL Study
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ZNS-00465, NCT00647049
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 08-087, NCT00739141
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 60
Sponsor: Other
Protocol IDs: 2008-0363, NCI-2012-01630, NCT00857389
Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years
Phase: Phase II
Type: Treatment
Status: Active
Age: 5 to 19
Sponsor: Other
Protocol IDs: PNET HR+ 5, CSET 1329, NCT00936156
Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: EudraCT 2007-006016-33, NCT00961142
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 65
Sponsor: Other
Protocol IDs: 2009-0266, NCI-2011-03144, NCT01010217
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 26
Sponsor: Other
Protocol IDs: L 10,321, NYMC 525, NCT01049854
High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: NHL-ZNS-Rezidiv, NCT01148173
Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SNUCH-SCT-1102, NCT01342237
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11D.51, 2010-54, NCT01349101
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11D.247, 2011-31, NCT01384513
Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 50
Sponsor: Other
Protocol IDs: OSII-TTP, 2009-009899-12, NCT00978471
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000721927, CALGB-51101, NCT01511562
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor
Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 19
Sponsor: Other
Protocol IDs: 12-053, NCT01598025
Start Over